University of Pennsylvania
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).
University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.
University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,423 total, page 6 of 29
Transportation Safety in Adolescence
NCT03639753
Post-Intensive Care Syndrome - Pediatrics (PICS-p): Longitudinal Cohort Study
NCT04967365
Implementing PrEP for Women Who Inject Drugs
NCT05360849
Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple Myeloma
NCT04680468
huCART19-IL18 in CD19+ Cancers
NCT04684563
Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks
NCT04779827
CONDUIT vs. PEEK Cages
NCT06904898
The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions
NCT04245423
Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects With OUD and Healthy Controls
NCT04401917
PennPET Explorer Scanner Evaluation
NCT04617912
Robot-Assisted Rehabilitation After HIV-Associated Stroke: Botswana
NCT04488250
Effects of Sitagliptin in Individuals With Genetically Decreased DPP4
NCT04323189
Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma
NCT04225039
Linking Tau PET to Medial Temporal Lobe Subregions With High Resolution MRI
NCT04251130
Compressed Intermittent Theta Burst Stimulation
NCT04684706
Evaluating Cascade Communication Methods
NCT04428736
The Physiological Chronobiome Modified by Age, Sex and Under Evoked Conditions
NCT04225442
Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease
NCT03933904
Clinic Navigation and Home Visits to Improve Guideline-based Care and Outcomes in Low Income Minority Adults With Asthma
NCT04023422
Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT
NCT04062526
CD4 CAR+ ZFN-modified T Cells in HIV Therapy
NCT03617198
Hyperfine Portable MRI in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging
NCT04436068
PROSpect: Prone and Oscillation Pediatric Clinical Trial
NCT03896763
Responsive Neurostimulation For Loss Of Control Eating
NCT03868670
TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
NCT03919435
Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT
NCT03846167
Itacitinib + Everolimus in Hodgkin Lymphoma
NCT03697408
Lentivirally Redirected CD123 Autologous T Cells in AML
NCT03766126
CART22 Alone or in Combination With huCART19 for ALL
NCT03620058
Oncology Episode Payment Model in Hawaii
NCT03523546
Hypertension Chronobiome
NCT03598894
Nicotinic Hepatic Metabolism on Neuroreceptor Substrates of Nicotine Addiction
NCT03442413
Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma
NCT03549442
Edema and Fibrosis CMR Imaging in Cardiomyopathy
NCT03534726
MCI: CPAP Treatment of OSA (Memories2)
NCT03113461
Air Pollution, Asthma and Circadian Clocks
NCT03406351
The University of Pennsylvania Uterus Transplant for Uterine Factor Infertility Trial
NCT03307356
Tau PET Imaging in the NACC Study Cohort
NCT03189485
Flu Vaccine Responses in the Setting of Melanoma Treatment
NCT03315975
Mapping the Shift Worker's Microbiome
NCT03221517
Migraine and CVD Risk in Women
NCT03081390
CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer
NCT03089203
Adrenergic System in Islet Transplantation
NCT03079921
Intravenous Estrogen in Kidney Transplant Study
NCT03663543
Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT
NCT02815917
CD22 Redirected Autologous T Cells for ALL
NCT02650414
[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer
NCT02608216
[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer
NCT02284919
Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT
NCT02379338
Memory Retrieval and Encoding Investigated by Neural Stimulation
NCT04286776
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 182 |
| Phase 2 | 157 |
| Phase 3 | 43 |
| Phase 4 | 87 |
Therapeutic Areas
What is open in the University of Pennsylvania pipeline
199 recruiting of 1,423 indexed (14% open); 982 completed (69%).
Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.